Fda Urges Pfizer Biontech And Moderna To Expand Trials For Kids 5 To 11
The goal of the expansion is to help detect the frequency of rare side effects in this age group, including myocarditis and pericarditis, health conditions that involve inflammation of different parts of the heart, according to The New York Times. Some people under the age of 30 have reported these health complications after receiving the COVID-19 vaccine. The FDA has asked both companies to increase the size of their clinical trials to include 3,000 children between the ages of 5 and 11, which is double the original number of study participants....